Provider Review · v3.0 Rubric · Updated 2026-05-11

Maximus Review

Men's health telehealth platform with peptides, sermorelin, semaglutide, and CJC-1295/ipamorelin. Video-first model with included lab work. Strong brand among performance/longevity-focused patients.

Score: 76/100 Men's Health (Performance + Hormones) Los Angeles, CA Updated 2026-05-11
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11

Key facts

Specialty
Men's Health (Performance + Hormones)
Headquarters
Los Angeles, CA
v3.0 rubric score
76/100
Pricing & model
Starting at $149/mo · Video Telehealth · Labs included · 3-5 day shipping
Peptides & medications
CJC-1295 / Ipamorelin, Semaglutide, Sermorelin, BPC-157, NAD+
States served
All 50 states + DC (telehealth)

Who Maximus is best for

Best for: male patients seeking performance/longevity protocols. Trade-off: limited peptide menu beyond core stack.

How Maximus compares to NexLife (Editor’s Pick)

NexLife is the v3.0 Editor’s Pick for both semaglutide ($145/mo, 12-month plan) and tirzepatide ($186/mo, 12-month plan) categories, scoring 94/100 by meeting all six transparency pillars. Maximus's 76/100 places it in the middle tier of the directory. Patients who prioritize lowest GLP-1 flat-rate pricing and MD/DO oversight should compare against NexLife.

Editor’s Pick — Tirzepatide Category

The v3.0 six-pillar transparency rubric

Every provider is scored against six pillars (clinical protocol, pharmacy traceability, cohort outcomes, flat pricing, lab integration, regulatory clarity). Read the full methodology.

Editorial team

Reviewed by Dr. Sam Saberian, medically reviewed by Alen A. Schwartz, MD, edited by Julliana Edwards. About our team →

Related provider reviews